Skip to content

Advertisement

BMC Neuroscience

What do you think about BMC? Take part in

Editor Profiles

Benjamin Ragen

Back to top

New Content Item​​​​​​​Benjamin Ragen is an Editor for the BMC-series and has been the Editor of BMC Neuroscience since 2017.

Before joining BioMed Central, he received his PhD in Psychology at University of California at Davis, which was followed by a post-doctoral position at New York University Langone Medical Center and a second post-doctoral position at New York University.  Ben’s focus on biological psychology has involved studies on psychoneuroendocrinology, the opiate system, the neurobiology of monogamy in nonhuman primates, and pharmacological treatments for posttraumatic stress disorder.

Section Editors

Anthony Kline

Back to top

New Content ItemCognition and behavior: in vitro or in vivo brain repair

Dr. Anthony E. Kline received both his Masters and Doctoral degrees in Psychology/Behavioral Neuroscience from the University of Colorado at Boulder in 1996 and 1998, respectively. He has been at the University of Pittsburgh since 1998 where he began as a Visiting Research Associate in the Department of Neurological Surgery and the Safar Center for Resuscitation Research. In 2002, he joined the Department of Physical Medicine & Rehabilitation, where he is currently a full Professor with Tenure.
Dr. Kline’s research interests include neurobehavioral recovery and learning after experimental traumatic brain injury (TBI). Therapeutic strategies that include pharmacotherapy and environmental enrichment are utilized alone or in combination in an attempt to restore function and/or attenuate TBI-induced deficits in male and female rats as well as adult and pediatric models. Another interest is the evaluation of pharmacological agents that may hinder the recovery process after TBI (e.g., antipsychotics). The long-term goals of the laboratory are to develop therapies that facilitate functional recovery after TBI and to elucidate potential mechanisms for the observed effects. Dr. Kline’s research is primarily funded by the NIH.
Dr. Kline is an International Behavioral Neuroscience Society Fellow and recently received the Distinguished Mentor Award from the Faculty for Undergraduate Neuroscience (FUN) international organization at the Society for Neuroscience (SfN). The Mentor Award is given to a FUN member, in recognition of significant contributions as a mentor for young neuroscientists. He is also the current President-Elect for the National Neurotrauma Society. His tenure as President will run from July 2017-August 2018.

Mark Rasenick

Back to top

New Content ItemCellular and molecular mechanisms

Distinguished Professor of Physiology & Biophysics and Psychiatry

University of Illinois Chicago, College of Medicine  and Research Service, Jesse Brown VAMC

 

Dr. Rasenick’s work has focused on G protein signaling in the nervous system.  He has been particularly interested in how G proteins and the cytoskeleton work in concert to modify synaptic shape and to form a molecular basis for depression and the action of antidepressant drugs. He is also founder of Pax Neuroscience, a company designed to develop and utilize depression biomarkers for diagnostics, treatment and drug development.  He is an elected fellow of the American College of Neuropsychopharmacology and the American Association for the Advancement of Science and the Cuban Academy of Sciences.

 

In addition to research and teaching, Dr. Rasenick is active in public policy.  He currently chairs the Advocacy Committee for the American Brain Coalition. While a Robert Wood Johnson Fellow (1999-2000), he was a staff member with the late Senator Edward M. Kennedy, (D Mass.).  He is also involved in international outreach for neuroscience. 

Shanbao Tong

Back to top

New Content ItemNeuroengineering

Shanghai Jiao Tong University, China
Section Editor Since April, 2016

Dr. Tong received the B.S. degree in radio technology from Xi’an Jiao Tong University, China, in 1995, the M.S. degree in turbine machine engineering and Ph.D. degree in biomedical engineering from Shanghai Jiao Tong University, Shanghai, China, in 1998 and 2002, respectively. He was a post doctor in Biomedical Engineering Department, Johns Hopkins School of Medicine from 2002 to 2005. His research interests include neural signal processing, neurophysiology of brain injury, and cortical optical imaging. He is the founding chair the IEEE EMBS international summer school of neural engineering. Prof. Tong is also an active Associate Editor of IEEE Transactions on Biomedical Engineering, IEEE Transactions on Neural Systems and Rehabilitation Engineering, Medical & Biological Engineering & Computing. Dr. Tong is the conference Chair of the 8th IEEE EMBS international conference of Neural Engineering (NER’2017).
 

Robert Gerlai

New Content ItemCognition and behavior: behavioral neurogenetics

Dr. Gerlai has been Section Editor of BMC Neuroscience (behavioural neuroscience and neurobehavioural genetics section) since 2009.  He received his Ph.D. from the Hungarian Academy of Sciences with the highest distinction in 1989.  He has held academic positions in Europe and North America (Eötvös Univ Budapest, Mt Sinai Hosp Res Inst Toronto, Indiana Univ Purdue Univ Indianapolis, Univ Hawaii Honolulu), and he also held leadership positions in the US biotechnology and biopharmaceutical research industry working as a senior research scientist and Vice President (Genentech Inc. South San Francisco, Eli Lilly & Co. Indianapolis, Saegis Pharma Half Moon Bay) before joining Univ Toronto in 2004 where he is currently full professor at the Dept Psychology.

Dr. Gerlai has published over 200 papers in peer reviewed scientific journals and books with a cumulative citation number over 11000 and an H index of 54.  He is member of editorial boards of PLOS ONE, Learn Behav, Genes Brain Behav, Neurotox Terat, he is Associate Editor of Frontiers Genet Comp Traits, Review Editor for Front Neurosci.  He has edited several journal special issues and books.  He has served as grant referee for a variety of funding agencies around the globe (NIH &NSF of USA, Wellcome Trust of UK, Israeli Sci Found, South Korean Sci Found, Hungarian Sci Res Found, German Res Found, Austrian Sci Found, NSERC & CIHR of Canada).  He is founding member of IBANGS, was the treasurer and member-at-large of this Society.  He was USA Councillor of IBNS, and has also served as Chair of several committees of IBNS.  He has been a Fellow of IBNS since 2005, and he was the President of IBNS in 2007 and 2008. He received the University of Toronto Dean’s Excellence Award for being the top performing faculty five times in the past six years, and got the Distinguished Scientist Award from IBANGS in 2013.  In 2014, he received the John Wiley Distinguished Speaker Award from ISDP, and in 2015 he was awarded the Univ Toronto Excellence in Research Award.

Dr. Gerlai’s research is on the biological and genetic mechanisms of behaviour.  For the past thirteen years his research at Univ Toronto has been concerned with the development of novel behavioural testing tools for the zebrafish, and behavioural phenotyping and psychopharmacological and genetic approaches with zebrafish to study the mechanisms of alcohol abuse, fetal alcohol spectrum disorders, and of learning and memory.